SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
22.06.22 | Novartis Neutral | UBS AG | |
22.06.22 | Novartis Underweight | JP Morgan Chase & Co. | |
22.06.22 | Novartis Sell | Deutsche Bank AG | |
16.06.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
07.06.22 | Roche Hold | Deutsche Bank AG | |
07.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
06.06.22 | Roche Neutral | JP Morgan Chase & Co. | |
27.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.05.22 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.05.22 | Roche Neutral | JP Morgan Chase & Co. | |
26.05.22 | Roche Hold | Deutsche Bank AG | |
26.05.22 | Roche Outperform | Bernstein Research | |
19.05.22 | Roche Neutral | Credit Suisse Group | |
13.05.22 | Roche Hold | Jefferies & Company Inc. | |
12.05.22 | Roche Equal-weight | Morgan Stanley | |
12.05.22 | Roche Hold | Deutsche Bank AG | |
11.05.22 | Roche Outperform | Bernstein Research | |
11.05.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
11.05.22 | Roche Overweight | Barclays Capital | |
11.05.22 | Roche Neutral | JP Morgan Chase & Co. | |
11.05.22 | Roche Sell | UBS AG | |
11.05.22 | Roche Buy | Jefferies & Company Inc. | |
05.05.22 | Roche Buy | Jefferies & Company Inc. | |
05.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
28.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
27.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
27.04.22 | Novartis Neutral | Credit Suisse Group | |
27.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
27.04.22 | Novartis Neutral | UBS AG | |
27.04.22 | Novartis Sell | Deutsche Bank AG | |
26.04.22 | Novartis Neutral | UBS AG | |
26.04.22 | Roche Neutral | Credit Suisse Group | |
26.04.22 | Roche Buy | Deutsche Bank AG | |
26.04.22 | Roche Overweight | Barclays Capital | |
26.04.22 | Novartis Buy | Jefferies & Company Inc. | |
26.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
25.04.22 | Roche Outperform | Bernstein Research | |
25.04.22 | Roche Sell | UBS AG | |
25.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
25.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. |